News

A new discovery about Group A Streptococcus may lead to the development of a new vaccine or antibiotic to prevent flesh-eating infections.

Navigating the difficult road of Clostridium difficile (C. difficile) surveillance, reporting, and reimbursement.

Death rates among HIV-positive patients diagnosed with cryptococcal meningitis were slightly lower when antiretroviral therapy was delayed a few weeks after diagnosis.

A recent study of Shiga toxin-producing Escherichia coli strains reports a high frequency of STEC antimicrobial resistance to drugs commonly used in human and veterinary medicine.

MNT occurs neonatally when a newborn’s unhealed umbilical stump is infected with Clostridium tetani, the bacterium that causes tetanus.

This study provides information on previously unidentified organisms, which has the potential to revolutionize the field of infectious disease and open doors for new therapeutics.

Made of a flexible silicone material, the ring contains dapivirine, a non-nucleoside reverse transcriptase inhibitor that blocks HIV’s ability to replicate inside of a healthy cell.

With new West Nile virus cases reported in California and Washington state, health officials are reminding the public that it’s not too late in the season to catch the mosquito-transmitted disease.

The CDC’s most recent Sexually Transmitted Disease Surveillance Report shows that the rates of sexually transmitted diseases have reached a record high in the United States.

Officials from the Los Angeles County Department of Public Health declare a local hepatitis A outbreak, as HAV outbreaks continue in San Diego and Santa Cruz.

New research on Zika virus transmission leads some investigators to suggest that the virus should be labeled a sexually transmitted infection.

Case Western Reserve University School of Medicine researchers identify accentuated risks for age-associated comorbidities in those living with HIV.

CDC investigators link large norovirus outbreak in Catalonia, Spain with office water coolers.

A new study reveals that direct-acting antivirals, like sofosbuvir, may help improve kidney function in some patients.

Phase 3 study shows that combination of elbasvir and grazoprevir is highly efficacious in hepatitis C virus (HCV) infected patients with inherited blood disorders.

Janssen Research & Development submits a new drug application for a darunavir-based once-daily, single-tablet regimen for the treatment of HIV in adults and adolescents 12 years and older.

A fast-paced world requires modern meat inspection processes, but are we lagging in our efforts?

Routine, rapid hepatitis C virus (HCV) testing may be a cost-effective method to help decrease the prevalence of new infections in high-risk communities.

In case you missed them, we've compiled the top 5 articles from this past week.

Following a deadly pneumonia outbreak in a Chinese hospital last year, researchers have identified a dangerous new superbug that is drug-resistant and highly virulent.

Despite thoughts that hookworm had been eradicated from the United States, a new study finds the parasite in Lowndes County, Alabama, begging the question—was it ever really gone?

The results of a new study have shown that an integrated care (IC) program can be successful in providing treatment to patients infected with hepatitis C virus (HCV) who were unlikely to respond to traditional outreach efforts.

One single-center study demonstrates that for patients with hospital stays of 1 week or less, reporting bacteriology results sooner may lead to earlier discharge.

The transition from youth to adult HIV care is a critical juncture that provides opportunities for continued engagement if handled well. What role should adult care clinics play to maximize the number of adolescents who stay in treatment?

UCLA researchers have shown that using molecular methods to predict susceptibility testing could serve as a new way to monitor drug-resistant gonorrhea.

As outbreaks of measles and mumps continue to spring up across the country, a third dose of the MMR vaccine may be necessary to cull their spread.

Researchers from the Moffitt Cancer Center find that the newest HPV vaccine protects against 9 cancer-causing strains of the virus.

New cases of West Nile virus springing up around the country are a reminder that the virus can continue to cause new infections well into fall, as mosquitoes continue to stay active where it’s still warm.